Abstract
From various studies it is now clear that in addition to nucleic acids, enediynes also target other biomolecules, the most prominent of which are the proteins. Since a major portion of currently available drug targets are proteins (enzymes and receptors), this aspect of enediyne chemistry has opened a new window for further exploitation. Newer enediyne-based therapeutics targeting proteins may be possible to design. Moreover, the toxicity of the natural enediynes may arise from the non-selective protein cleavages. Substantial progress has been made to understand the nature of interaction between enediynes and proteins. This article is an attempt to discuss the developments in this area.
Keywords: Bergman cyclization, cycloaromatization, diradicals, dna, enediynes, protein.
Letters in Drug Design & Discovery
Title:Proteins as Alternate Targets of Enediynes
Volume: 12 Issue: 7
Author(s): Hussam M. Bdour, Snigdha Roy and Amit Basak
Affiliation:
Keywords: Bergman cyclization, cycloaromatization, diradicals, dna, enediynes, protein.
Abstract: From various studies it is now clear that in addition to nucleic acids, enediynes also target other biomolecules, the most prominent of which are the proteins. Since a major portion of currently available drug targets are proteins (enzymes and receptors), this aspect of enediyne chemistry has opened a new window for further exploitation. Newer enediyne-based therapeutics targeting proteins may be possible to design. Moreover, the toxicity of the natural enediynes may arise from the non-selective protein cleavages. Substantial progress has been made to understand the nature of interaction between enediynes and proteins. This article is an attempt to discuss the developments in this area.
Export Options
About this article
Cite this article as:
Bdour M. Hussam, Roy Snigdha and Basak Amit, Proteins as Alternate Targets of Enediynes, Letters in Drug Design & Discovery 2015; 12 (7) . https://dx.doi.org/10.2174/1570180812666150213224756
DOI https://dx.doi.org/10.2174/1570180812666150213224756 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Study about How A Sample of Portuguese People Perceive the Health Benefits of Dietary Fibre
Current Nutrition & Food Science Reversion of Multidrug Resistance in Tumor By Biocompatible Nanomaterials
Mini-Reviews in Medicinal Chemistry Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology Therapeutic Agents Based on DNA Sequence Specific Binding
Current Topics in Medicinal Chemistry Metallothioneins and Cancer
Current Protein & Peptide Science Network Medicine and High Throughput Screening
Current Drug Discovery Technologies III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design Construction and Analysis of mRNA and lncRNA Regulatory Networks Reveal the Key Genes Associated with Prostate Cancer Related Fatigue During Localized Radiation Therapy
Current Bioinformatics Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease
Current Alzheimer Research Germline Genetics of the p53 Pathway Affect Longevity in a Gender Specific Manner
Current Aging Science New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design Applications of Aptamers in Targeted Imaging: State of the Art
Current Topics in Medicinal Chemistry Circulating Tumor Cells in Cancer Therapy: Are we off Target?
Current Cancer Drug Targets The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Graphical Abstracts
Anti-Cancer Agents in Medicinal Chemistry Breast Cancer: A Review of Risk Factors and New Insights into Treatment
Current Cancer Therapy Reviews Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews